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Abstract
Background: Cystic Fibrosis is a pleiotropic disease in humans with primary morbidity and
mortality associated with a lung disease phenotype. However, knockout in the mouse of cftr, the
gene whose mutant alleles are responsible for cystic fibrosis, has previously failed to produce a
readily, quantifiable lung phenotype.
Results: Using measurements of pulmonary mechanics, a definitive lung phenotype was
demonstrated in the cftr-/- mouse. Lungs showed decreased compliance and increased airway
resistance in young animals as compared to cftr+/+ littermates. These changes were noted in
animals less than 60 days old, prior to any long term inflammatory effects that might occur, and are
consistent with structural differences in the cftr-/- lungs. Surprisingly, the cftr+/- animals exhibited
a lung phenotype distinct from either the homozygous normal or knockout genotypes. The
heterozygous mice showed increased lung compliance and decreased airway resistance when
compared to either homozygous phenotype, suggesting a heterozygous advantage that might
explain the high frequency of this mutation in certain populations.
Conclusions: In the mouse the gene dosage of cftr results in distinct differences in pulmonary
mechanics of the adult. Distinct phenotypes were demonstrated in each genotype, cftr-/-, cftr +/-,
and cftr+/+. These results are consistent with a developmental role for CFTR in the lung.
Background
Cystic fibrosis (CF) is a progressive disease primarily
affecting the intestines, lungs, and pancreas. The gene
responsible for CF was identified in 1989 [1] as coding for
the cystic fibrosis transmembrane conductance regulator
(cftr), a membrane chloride channel. CF is one of the most
common autosomal recessive diseases in Caucasians with
a carrier rate of 3–4% [2], and is characterized by recurrent
infection and chronic inflammation. Recently it was
found that infants with CF demonstrate changes in forced
expiratory volume in 1 second (FEV1), functional residual
capacity (FRC), and other parameters of lung function
prior to the onset of recurrent infection [3-5].
Soon after the CF gene was discovered, a knockout mouse
was developed. This mouse demonstrates subtle changes
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tory glycoconjugates and changes in secretory vesicles [6].
Monocytic infiltrates and altered lung mechanics have
also been found [7]. Unfortunately, the cftr knockout
mouse does not develop overt lung disease, which has
severely limited its usefulness. However, the availability of
new methods for pulmonary testing in rodents [8,9] now
presents the opportunity to re-examine the cftr knockout
mouse for functional lung changes. In the present study,
therefore, we examined pulmonary function in young
adult cftr -/-, cftr +/-, and cftr+/+ S489x mice in an effort to
establish a lung phenotype.
Results
Effect of cftr gene dosage on pressure-volume (PV) curves
Routine evaluation of dynamic lung function employs the
stepwise variation in air volume on both the inflation and
deflation phases of a single breath. Measurement of air-
way pressures at each step results in the classic pressure-
volume (PV) curve which is dependent upon both lung
structure and interfering pathology. PV curves were meas-
ured in triplicate, starting from positive end-expiratory
pressure (PEEP) values of 0, 3, and 6 cmH2O in S489X
mice at 30–60 days of age following genotyping for the
normal and mutant cftr alleles. The 3 cmH2O PEEP curves
obtained for each genotype are presented in Figure 1A.
Note that these PV curves all begin at V = 0 ml, which is
the FRC defined by the 3 cmH2O PEEP. The PV curves
obtained at PEEP levels of 0 and 6 cmH2O were similar.
The static compliance (Cst) of the lungs, which reflects
elastic recoil at a given pressure, was calculated from the
slopes of the PV curves. As shown in Figure 1B, the static
compliance of the homozygous knockout lung was signif-
icantly decreased compared to the homozygous normal
lung (p < 0.01)). Furthermore, Cst was significantly
reduced in both cftr+/+ (p < 0.001) and cftr-/- (p < 0.001)
as compared to age-matched cftr+/- mice. Hysteresis was
altered among the 3 genotypes (Figure 1C). A statistically
significant increase in hysteresis was observed in both
cftr+/- (P < 0.0001) and cftr+/+ mice (p < 0.05) compared
to cftr-/- mice. These data suggest the presence of a gene
dosage effect in which an altered lung structure in the het-
erozygous animals leads to an elevated compliance rela-
tive to the two homozygous animals. Lung weights were
measured and no statistically significant differences were
observed among the three genotypes (Figure 1D).
Airway mechanics of cftr deficient lungs
We applied the forced oscillation method to the mice and
determined respiratory mechanical input impedance
[10,11]. We fit the constant-phase model of respiratory
mechanics [12] to impedance (Zrs) and determined val-
ues for airway resistance (Raw), tissue damping (G), and
tissue elastance (H). Figure 2 shows that Raw, G, and H
were significantly reduced in the cftr+/- mice as compared
to both cftr+/+ and cftr-/- animals (Panels A, C, & D) at all
PEEP levels. Raw also decreased with PEEP in a similar
fashion in all three genotypes. In contrast, Raw, H and G
were significantly increased in the cftr-/- mice compared
with cftr+/+ and cftr+/-, and showed a greater dependence
on PEEP (Panels A, C & D). The ratio G/H, termed hyster-
esivity (both the low and high frequency), was not signif-
icantly affected by either genotype or PEEP (Panel E).
Thus, the absence of either 1 or 2 copies of the cftr gene
had significantly different effects on the phenotype of the
lung. Paradoxically, the absence of only one cftr copy
resulted in a greater lung compliance (lower elastance)
than if neither or both copies were present.
Discussion
The usefulness of the cftr knockout mouse as a model of
cystic fibrosis has been severely limited by its failure to
demonstrate readily measurable lung disease, the primary
cause of morbidity and mortality in humans [13]. How-
ever, in the present study use of sophisticated measure-
ments of lung function revealed a functional lung
phenotype in the knockout mouse (Table 1); the com-
plete absence of cftr in the lung of young adult animals
resulted in decreased Cst and η and increased Raw, G and
H as compared to normal littermate controls.
A particularly intriguing further observation was that Cst
and hysteresis in cftr+/- mice was significantly higher than
in cftr+/+ animals while G and H were decreased. As this
was not associated with any pathology such as emphy-
sema, we conclude that it represents a functionally differ-
ent lung from that of the cftr+/+. Our data thus reveal a
remarkable inverse correlation between the effect of one
and two non-functional copies of the cftr gene.
What do these data mean in terms of lung structure? The
knockout animal has cystic fibrosis by definition, and our
data now show it to also have lung disease manifest as a
reduced compliance and increased resistance. These
changes could reflect changes in the intrinsic mechanical
properties of the parenchyma, or simply a reduction in
lung volume. The former effect could include alterations
in the biophysical properties of the air-liquid interface in
the lungs, and would be expected to result in a change in
η[14]. Indeed, because cftr is a chloride channel and is
thought to be involved in water balance, a change in sur-
face tension in the lung, and consequently in η, might be
expected. However, as shown in Figure 2 and Table 1,
although G and H both increase, they do so in the same
proportion so there is no significant change in η between
the three cftr genotypes. On the other hand, lung weights
were not different among the different groups of mice, so
the decreased compliance and increased resistance of the
cftr-/- animals was not simply due to their having smallerPage 2 of 6
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Relationship between cftr genotypes and PV curves. Littermates from 30–60 days of age were genotyped and individuals 
with cftr+/+ (Black), cftr+/- (Green), and cftr-/-(Red) were evaluated using pressure volume curve analysis at Peeps of 0, 3, and 
6. A: PV curve at PEEP 3; B: Calculated Cst for all PV curves; C: Calculated hysteresis for PV curves in A. All measures were cor-
rected individually for lung weight. Error bars are +/- standard deviation. *p < 0.05 when compared to cftr+/+ and **p < 0.05 
when compared to cftr+/-.Page 3 of 6
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chymal structure in the lungs of the homozygous and het-
erozygous animals were organized differently, in a
manner that affected G and H similarly.
As documented in numerous publications, the mouse
strain used in the present study does not develop chronic
inflammatory disease up to the age (30–60 days) used in
this study (for review see [15]). On the other hand,
Variation in respiratory mechanic among cftr genotypesFigure 2
Variation in respiratory mechanic among cftr genotypes. Values for Raw(A), G(B), H(C), and η(D) were determined by 
fitting the constant-phase model to measurements of Zrs from cftr+/+ (Black), cftr+/- (Green) and cftr-/- (red) genotypes. All 
measures were normalized by multiplication by lung weight. Error bars are +/- standard deviation. *p < 0.05 when compared to 
cftr+/+ and **p < 0.05 when compared to cftr+/-.
Table 1: Relative effect of genotype on lung function compared to that observed in the cftr+/+ mouse.
Genotype PV curve 
position
Cst PV Hysteresis Raw G H η
cftr+/- ← ↑ ↑ ↓ ↓ ↓ ↔
cftr-/- → ↓ ↓ ↑ ↑ ↑ ↔Page 4 of 6
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highest in the developing lung and decrease 75-fold at
birth. In utero over-expression of cftr has also been shown
to affect lung growth and development[17], and the sever-
ity of disease in the knockout mouse has been shown to
be influenced by genetic background [18]. These data thus
suggest that cftr may affect the early development of the
lung in a manner that is affected by the interaction of
other genes.
Are there any functional consequences for increased lung
compliance in the heterozygous cftr animals? Interest-
ingly, there is no decrement in lung function in human
heterozygotes [19-21]. Also, the heterozygote frequency
for CF in humans is higher than expected, likely reflecting
a selective advantage because there is no evidence for
genetic drift [22,23]. Indeed, selective advantage in CF has
been proposed to reflect resistance to tuberculosis, influ-
enza and cholera [24]. When one looks in nature for other
examples of heterozygous advantage, the sickle cell trait
which confers resistance to malaria [25] is perhaps the
only such recognized genetic trait in humans. In Norway
rats, a single Mendelian gene controls resistance to Warfa-
rin, an anticoagulant used to control rat populations;
homozygous wild-type rats are killed by Warfarin and
homozygous mutant allele animals are highly susceptible
to vitamin K deficiency [26]. The results of the present
study indicate that a similar selective advantage may per-
tain to cftr, something we term a "Goldilocks Effect". That
is, while two defective copies of the gene are detrimental
and two normal copies are satisfactory, one normal and
one defective gene may results in an optimal dosage for
lung development.
Further studies of pulmonary mechanics in cftr knockout
mice should reveal additional genetic loci that modulate
the influence of cftr on lung growth and development.
Corresponding studies in humans should be useful in
evaluating the effect of therapies on reversing altered pul-
monary function in the CF patient.
Conclusions
Using sophisticated techniques to a evaluate rodent pul-
monary function; a distinct, readily quantifiable lung phe-
notype was identified in the cftr knockout mouse. In
addition, the cftr+/- mouse had a distinguishable pulmo-
nary function phenotype from that observed in either the
homozygous normal or mutant genotype mice. These
data are consistent with CFTR-dependent, physiologic
changes in the structure and function of the lung.
Methods
Mouse strain
The S489X mouse 5th generation backcross to C57Bl/6 has
been maintained by random mating for the past 8 years.
This colony has a 100% mortality rate among cftr knock-
outs by 45 days of age unless the animals are placed on an
elemental liquid diet and corncob bedding upon weaning
[27]. Mice 30–60 days of age from our S489X mouse col-
ony were genotyped for the normal and mutant cftr alle-
les. Age and litter matched cftr+/+ and cftr+/- were used for
each cftr-/- mouse examined. Six animals were included in
each group. All experiments were approved by the animal
care and use committee.
Pulmonary function tests
The mice were anesthetized with intra-peritoneal pento-
barbital (90 mg/kg) and the trachea was dissected free of
surrounding tissue and cannulated with a 20-gauge can-
nula. The animals were then connected to a small animal
ventilator (flexiVent, SCIREQ Inc. Montreal, PQ, Canada)
and ventilated with a tidal volume of 10 ml/kg; inspira-
tory:expiratory ratio of 66.67%, respiratory rate of 150
breaths/minute, and maximum pressure of 30 cmH20.
PEEP was controlled by submerging the expiratory limb
from the ventilator into a water trap. Each animal was par-
alyzed with pancuronium bromide (0.5 mg/kg) and
allowed to equilibrate on the ventilator until spontaneous
breathing ceased (5 minutes).
Respiratory mechanics
To measure Zrs, mechanical ventilation was interrupted
and the animal was allowed to expire against the set level
of PEEP for 1 s. We then applied an 8 s broad-band vol-
ume perturbation signal to the lungs with the flexiVent,
after which ventilated was resumed. This was repeated at
PEEP levels of 0, 3 and 6 cmH2O. The volume perturba-
tion signal consisted of the superposition of 18 sine waves
having frequency spaced roughly evenly over the range
0.25 Hz to 19.625 Hz. Zrs was calculated from the dis-
placement of the ventilator's piston and the pressure in its
cylinder as described previously [10,11]. Correction for
gas compressibility as well as resistive and accelerative
losses in the flexiVent, connecting tubing and the tracheal
cannula were performed as described previously [28]
using dynamic calibration data obtained by applying vol-
ume perturbations through the tubing and tracheal can-
nula first when it was completely closed and then when it
was open to the atmosphere.
We interpreted the measurement of Zrs in terms of the
constant phase model [12]
where Raw is a frequency independent Newtonian resist-
ance reflecting that of the conducting airways[29], Iaw is
airway gas inertance, G characterizes tissue damping, H
characterizes tissue stiffness (elastance), i is the imaginary
Zrs f Raw i fIaw
G iH
f
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unit, α links G and H, and f is frequency. We also
calculated a quantity known as hysteresivity (η = G/H),
which is believed to increase when regional heterogenei-
ties develop in the lung [30]. Raw, G and H were all nor-
malized by multiplication by lung weight.
PV curves
Starting at the FRC defined by the PEEP, the flexiVent was
programmed to deliver seven inspiratory volume steps for
a total volume of 0.8 ml followed by seven expiratory
steps, pausing at each step for 1 s. Plateau pressure (P) at
each step was recorded and related to the total volume (V)
delivered to produce a quasi-static PV curve. Cst was calcu-
lated from the slope of each curve [31], and was normal-
ized by division by lung weight.
Zrs measurements at each PEEP level and PV curves were
obtained in triplicate. Data were statistically evaluated
using paired t-test with p < 0.05 being taken as significant
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